+Compare
THMO
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
2.73M

THMO ThermoGenesis Holdings Forecast, Technical & Fundamental Analysis

a company, which engages in the research, development, commercialization and marketing of automated technologies for cell-based therapies for use in regenerative medicine

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for THMO with price predictions
07:00 PM EST Dec 06, 2023

Momentum Indicator for THMO turns negative, indicating new downward trend

THMO saw its Momentum Indicator move below the 0 level on November 17, 2023. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned negative. In of the 82 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

THMO moved below its 50-day moving average on November 14, 2023 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where THMO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

THMO broke above its upper Bollinger Band on November 13, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for THMO entered a downward trend on December 07, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where THMO's RSI Oscillator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where THMO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for THMO just turned positive on December 05, 2023. Looking at past instances where THMO's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where THMO advanced for three days, in of 215 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.587) is normal, around the industry mean (25.240). P/E Ratio (1.865) is within average values for comparable stocks, (79.553). Projected Growth (PEG Ratio) (1.857) is also within normal values, averaging (6.249). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.278) is also within normal values, averaging (44.190).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. THMO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. THMO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NASDAQ:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NASDAQ:MDT), Boston Scientific Corp (NASDAQ:BSX), Edwards Lifesciences Corp (NASDAQ:EW), IQVIA Holdings (NASDAQ:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.41B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -0%. For the same Industry, the average monthly price growth was 10%, and the average quarterly price growth was -10%. SERA experienced the highest price growth at 160%, while IMMVF experienced the biggest fall at -95%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -51%. For the same stocks of the Industry, the average monthly volume growth was -20% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 84
Profit Risk Rating: 87
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published General Information

General Information

a company, which engages in the research, development, commercialization and marketing of automated technologies for cell-based therapies for use in regenerative medicine

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
2711 Citrus Road
Phone
+1 916 858-5100
Employees
41
Web
https://www.thermogenesis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YSG0.800.01
+1.51%
Yatsen Holding Limited
PGTI32.710.23
+0.71%
PGT
X35.930.12
+0.34%
United States Steel Corp
SPCB0.38-0.02
-4.60%
SuperCom Ltd
TORO4.41-0.22
-4.75%
Toro Corp

THMO and

Correlation & Price change

A.I.dvisor tells us that THMO and STRRP have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that THMO and STRRP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THMO
1D Price
Change %
THMO100%
-5.42%
STRRP - THMO
27%
Poorly correlated
N/A
CORBF - THMO
26%
Poorly correlated
-4.00%
HBIO - THMO
25%
Poorly correlated
+3.98%
GENE - THMO
23%
Poorly correlated
-0.50%
BFLY - THMO
23%
Poorly correlated
-5.26%
More

Groups containing THMO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THMO
1D Price
Change %
THMO100%
-5.42%
Medical Specialties
(undefined stocks)
9%
Poorly correlated
-0.02%
Medical Specialties
(undefined stocks)
9%
Poorly correlated
-0.02%